[1]
2024. 39. SYSTEMATIC REVIEW OF THE EFFICARY, SAFETY AND COST-EFFECTIVENESS OF MIRABEGRON IN COMPARISON WITH SOLIFENACIN IN THE TREATMENT OF OVERACTIVE BLADDER. Vietnam Journal of Community Medicine. 65, CĐ 7 - NCKH (July 2024). DOI:https://doi.org/10.52163/yhc.v65iCD7.1334.